EBERSBERG, Germany–(BUSINESS WIRE)–Oct 27, 2020–
Eurofins Genomics (Paris:ERF), Eurofins BioDiagnostics and Medicinal Genomics Corp (MGC), introduced the formal launch of business SNP genotyping providers for hemp and medicinal hashish breeders. The newly launched CannSNP90 genotyping assay relies on industry-leading array platforms and will assist prospects with their efforts to develop hemp and hashish cultivars that exhibit particular chemical profiles and illness resistant traits.
This new assay is meant to supply the greatest genetic answer for shoppers, serving to them revolutionize breeding, genetic purity, and help IP round hemp and hashish traces. Eurofins Genomics and Medicinal Genomics are amongst the premier suppliers of genetic evaluation options for detection of genetic traits.
The chip was developed utilizing Kannapedia®, the world’s largest hashish genomic database accessible by way of Medicinal Genomics, leveraging over 75,000 distinctive genetic options. Along with tens of hundreds of high-impact coding SNPs, there are markers for 39 cannabinoid genes, plant intercourse, chemotypes (I-IV), and illness resistance captured on the array. These traits are the most vital in the market. The knowledge from the chip may be additional analyzed utilizing Kannapedia to collect inhabitants frequencies, Bt:Bd allele protection, heterozygosity, relatedness to different cultivars and different genetic information in the database.
This product has the potential for not simply breeding, authentication and genotyping functions but in addition for additional analysis in the subject, finally serving to prospects carry to market secure and additionally revolutionary merchandise.
A one-hour webinar on functions and use of the chip is deliberate for November 2020. Companies curious about studying extra can register at: https://www.eurofinsus.com/biodiagnostics/resources/webinars/cannsnp90
The CannSNP90 chip is now accessible for orders.
For US-based entities go to www.medicinalgenomics.com/cannsnp90
For world prospects exterior the US go to https://go.eurofinsgenomics.eu/cannabis-hemp-testing/ or electronic mail: DNACannabis@eurofins.com
With over 50,000 workers throughout a community of greater than 800 laboratories in over 50 international locations, Eurofins’ firms supply a portfolio of over 200,000 analytical strategies.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
About Medicinal Genomics Corporation
Medicinal Genomics Corporation is a pioneer in advancing the genomics of hashish to construct a stronger scientific basis for cannabis-based merchandise. The firm’s unmatched experience in genetic science helps prospects characterize and perceive the high quality and consistency of hashish to make sure sufferers and customers entry to persistently secure, prime quality hashish. For extra data, please go to www.medicinalgenomics.com.